Xenical OTC Actual Use Trial Shows Dose Compliance, Glaxo Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Abuse was “extremely low” Glaxo researchers report at Vancouver meeting of the Obesity Society. Three-month, pharmacy-based trial offered 60 mg orlistat over-the-counter to consumers 18 and older.